Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Brunet

Showing results (221-230 of 492) with videos related to

Pageof 50
Sort By:
Annals of Hematology|December 6, 2001
Predictive factors for a successful mobilization of peripheral blood CD34+ cells in multiple myelomaG Perea, A Sureda, R Martino, et al.
Bone Marrow Transplantation|August 5, 2000
Mobilization kinetics of peripheral blood progenitor cells after IAPVP-16 salvage chemotherapy plus G-CSF in lymphoproliferative disordersA Altés, R López, R Martino, et al.
Leukemia Research|April 24, 2012
Adverse impact of IDH1 and IDH2 mutations in primary AML: experience of the Spanish CETLAM groupJ Nomdedéu, M Hoyos, M Carricondo, et al.
Lancet (London, England)|December 10, 1999
Pregnancy and risk of early breast cancer in carriers of BRCA1 and BRCA2H Jernström, C Lerman, P Ghadirian, et al.
Bone Marrow Transplantation|July 1, 1996
Retrospective evaluation of autologous bone marrow transplantation vs allogeneic bone marrow transplantation from an HLA identical related donor in acute myelocytic leukemia. A study of the European Cooperative Group for Blood and Marrow Transplantation (EBMT)N C Gorin, M Labopin, L Fouillard, et al.
Bone Marrow Transplantation|January 11, 2000
Mini-ICE regimen as mobilization therapy for chronic myelogenous leukaemia patients at diagnosisA Sureda, J Petit, S Brunet, et al.
Bone Marrow Transplantation|July 27, 2004
Risk assessment and outcome of chronic graft-versus-host disease after allogeneic peripheral blood progenitor cell transplantation in pediatric patientsM A Diaz, M G Vicent, M E Gonzalez, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 16, 2000
Primary node negative breast cancer in BRCA1 mutation carriers has a poor outcomeW D Foulkes, P O Chappuis, N Wong, et al.
Bone Marrow Transplantation|December 12, 2019
Incorporating posttransplant cyclophosphamide-based prophylaxis as standard-of-care outside the haploidentical setting: challenges and review of the literatureI García-Cadenas, R Awol, A Esquirol, et al.
Haematologica|March 21, 1998
High incidence of chronic graft versus host disease after allogeneic peripheral blood progenitor cell transplantation. The Spanish Group of Allo-PBPCTA Urbano-Ispizua, J García-Conde, S Brunet, et al.
Pageof 50

Showing results (221-230 of 492) with videos related to

Sort By:
Pageof 50
Annals of Hematology|December 6, 2001
Predictive factors for a successful mobilization of peripheral blood CD34+ cells in multiple myelomaG Perea, A Sureda, R Martino, et al.
Bone Marrow Transplantation|August 5, 2000
Mobilization kinetics of peripheral blood progenitor cells after IAPVP-16 salvage chemotherapy plus G-CSF in lymphoproliferative disordersA Altés, R López, R Martino, et al.
Leukemia Research|April 24, 2012
Adverse impact of IDH1 and IDH2 mutations in primary AML: experience of the Spanish CETLAM groupJ Nomdedéu, M Hoyos, M Carricondo, et al.
Lancet (London, England)|December 10, 1999
Pregnancy and risk of early breast cancer in carriers of BRCA1 and BRCA2H Jernström, C Lerman, P Ghadirian, et al.
Bone Marrow Transplantation|July 1, 1996
Retrospective evaluation of autologous bone marrow transplantation vs allogeneic bone marrow transplantation from an HLA identical related donor in acute myelocytic leukemia. A study of the European Cooperative Group for Blood and Marrow Transplantation (EBMT)N C Gorin, M Labopin, L Fouillard, et al.
Bone Marrow Transplantation|January 11, 2000
Mini-ICE regimen as mobilization therapy for chronic myelogenous leukaemia patients at diagnosisA Sureda, J Petit, S Brunet, et al.
Bone Marrow Transplantation|July 27, 2004
Risk assessment and outcome of chronic graft-versus-host disease after allogeneic peripheral blood progenitor cell transplantation in pediatric patientsM A Diaz, M G Vicent, M E Gonzalez, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 16, 2000
Primary node negative breast cancer in BRCA1 mutation carriers has a poor outcomeW D Foulkes, P O Chappuis, N Wong, et al.
Bone Marrow Transplantation|December 12, 2019
Incorporating posttransplant cyclophosphamide-based prophylaxis as standard-of-care outside the haploidentical setting: challenges and review of the literatureI García-Cadenas, R Awol, A Esquirol, et al.
Haematologica|March 21, 1998
High incidence of chronic graft versus host disease after allogeneic peripheral blood progenitor cell transplantation. The Spanish Group of Allo-PBPCTA Urbano-Ispizua, J García-Conde, S Brunet, et al.
Pageof 50